<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Lab Physicians</journal-id><journal-id journal-id-type="iso-abbrev">J Lab Physicians</journal-id><journal-id journal-id-type="publisher-id">JLP</journal-id><journal-title-group><journal-title>Journal of Laboratory Physicians</journal-title></journal-title-group><issn pub-type="ppub">0974-2727</issn><issn pub-type="epub">0974-7826</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22923917</article-id><article-id pub-id-type="pmc">3425259</article-id><article-id pub-id-type="publisher-id">JLP-4-17</article-id><article-id pub-id-type="doi">10.4103/0974-2727.98665</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of Exercise Therapy on Lipid Parameters in Patients with End-Stage Renal Disease on Hemodialysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gordon</surname><given-names>Lorenzo</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>McGrowder</surname><given-names>Donovan A</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Pena</surname><given-names>Yeiny T</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Cabrera</surname><given-names>Elsa</given-names></name><xref ref-type="aff" rid="aff4">3</xref></contrib><contrib contrib-type="author"><name><surname>Lawrence-Wright</surname><given-names>Marilyn</given-names></name><xref ref-type="aff" rid="aff5">4</xref></contrib></contrib-group><aff id="aff1">Kingston Public Hospital, North Street, Kingston, Jamaica</aff><aff id="aff2"><label>1</label>Department of Pathology, Faculty of Medical Sciences, University of the West Indies, Kingston 7, Jamaica</aff><aff id="aff3"><label>2</label>Department of Medicine, May Pen Hospital, Clarendon, Jamaica</aff><aff id="aff4"><label>3</label>Department of Postgraduate Studies and Teaching, Hermanos Ameijeiras Hospital, Havana, Cuba</aff><aff id="aff5"><label>4</label>Department of Medicine, Faculty of Medical Sciences, University of the West Indies, Kingston 7, Jamaica</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Lorenzo Gordon, E-mail: <email xlink:href="lorenzogordon@yahoo.com">lorenzogordon@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Jun</season><year>2012</year></pub-date><volume>4</volume><issue>1</issue><fpage>17</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright: &#x000a9; Journal of Laboratory Physicians</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Dyslipidemia has been established as a well-known traditional risk factor for cardiovascular disease in chronic kidney disease patients.</p></sec><sec id="st2"><title>Aim:</title><p>This study investigated the impact of Hatha yoga exercise on lipid parameters in patients with end-stage renal disease (ESRD) on hemodialysis.</p></sec><sec id="st3"><title>Materials and Methods:</title><p>This prospective randomized study consisted of 33 ESRD patients in the <italic>Hatha yoga</italic> exercise group that was matched with 35 ESRD patients in the control group. Serum total cholesterol, triglycerides, low-density lipoprotein (LDL)-cholesterol, and high-density lipoprotein (HDL)-cholesterol were determined at baseline (0 month) and after 4 months.</p></sec><sec id="st4"><title>Results:</title><p>Comparing values after 4 months versus baseline in the prehemodialysis Hatha yoga exercise group, there was found a significant decrease in total cholesterol from 5.126 &#x000b1; 0.092 mmol/l to 4.891 &#x000b1; 0.072 mmol/l (-4.58%; <italic>P</italic> = 0.0001), triglycerides from 2.699 &#x000b1; 0.078 mmol/l to 2.530 &#x000b1; 0.063 mmol/l (-6.26%; <italic>P</italic> = 0.0001), LDL-cholesterol from 2.729 &#x000b1; 0.083 mmol/l to 2.420 &#x000b1; 0.066 mmol/l (-11.32%; <italic>P</italic> = 0.0001), and total cholesterol/HDL-cholesterol ratio from 5.593 &#x000b1; 0.119 mmol/l to 4.907 &#x000b1; 0.116 mmol/l (-12.26%; <italic>P</italic> = 0.047). For patients in the Hatha yoga exercise group, 51.5% had normal total cholesterol at 0 month while 70.0% had normal total cholesterol (<italic>P</italic> &#x0003c; 0.05) after 4 four months and 54.5% of patients had normal LDL-cholesterol at 0 month while 84.9% had normal LDL-cholesterol after 4 months (<italic>P</italic> &#x0003c; 0.05).</p></sec><sec id="st5"><title>Conclusion:</title><p>These findings suggest that <italic>Hatha yoga</italic> exercise has preventive and beneficial effects and may be a safe therapeutic modality in ESRD patients.</p></sec></abstract><kwd-group><kwd>Cardiovascular</kwd><kwd>end-stage renal disease</kwd><kwd>hatha yoga exercise</kwd><kwd>total cholesterol</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>INTRODUCTION</title><p>Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with chronic kidney disease (CKD),[<xref ref-type="bibr" rid="ref1">1</xref><xref ref-type="bibr" rid="ref2">2</xref>] and is the leading cause of death in hemodialysis patients accounting for almost 50 percent of deaths.[<xref ref-type="bibr" rid="ref3">3</xref>] The number of patients with CKD is increasing due to premature CVD that manifests itself as a coronary heart disease (CHD).[<xref ref-type="bibr" rid="ref4">4</xref>] Premature atherosclerotic CHD is driven by multiple risk factors, including dyslipidemia and oxidative stress, and there is evidence that end-stage renal disease (ESRD) patients on hemodialysis have atherogenic lipid abnormalities.[<xref ref-type="bibr" rid="ref5">5</xref>]</p><p>The incidence of CVD is high in patients on hemodialysis and approximately two-thirds of all patients with ESRD suffer from dyslipidemia.[<xref ref-type="bibr" rid="ref6">6</xref>] Dyslipidemia has been established as a well-known traditional risk factor for CVD in CKD patients on maintenance hemodialysis and contributes to the high cardiovascular morbidity and mortality in these patients.[<xref ref-type="bibr" rid="ref7">7</xref>] Further, dyslipidemia is highly prevalent in patients on maintenance hemodialysis, with predominance of the atherogenic triad, i.e., hypertriglyceridemia, elevated very low-density lipoprotein (VLDL) and reduced high-density lipoprotein (HDL).[<xref ref-type="bibr" rid="ref8">8</xref>] Hemodialysis patients also display elevated concentration of lipoprotein-a (LP-a), and total and low-density lipoprotein (LDL)-cholesterol levels usually remain within normal limits.[<xref ref-type="bibr" rid="ref9">9</xref>] The kidney dialysis outcome quality initiative guidelines state that patients on maintenance hemodialysis with fasting triglycerides &#x0003e;5.65 mmol/l, LDL-cholesterol &#x0003e;2.59 mmol/l, and non-HDL-cholesterol &#x0003e;3.36 mmol/l, should be considered for treatment to reduce the cardiovascular complications in these patients.[<xref ref-type="bibr" rid="ref10">10</xref>]</p><p>Patients with CKD are inactive and are characterized by severe functional limitations.[<xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref12">12</xref>] Although renal replacement treatment options, such as hemodialysis or peritoneal dialysis, reduce morbidity and mortality, ESRD patients still experience significantly low physical fitness and poor quality of life.[<xref ref-type="bibr" rid="ref13">13</xref><xref ref-type="bibr" rid="ref14">14</xref>] Their cardio-respiratory capacity is reported to be dramatically low.[<xref ref-type="bibr" rid="ref15">15</xref>] The maximum oxygen consumption (VO<sub>2</sub> max) in ESRD patients on hemodialysis is reported to be from 15.0 to 21.0 ml/kg/min, values that are half of those reported for healthy sedentary subjects, which range from 35.0 to 40.0 ml/kg/min.[<xref ref-type="bibr" rid="ref16">16</xref><xref ref-type="bibr" rid="ref17">17</xref>] Aerobic exercise interventions have been shown to increase VO<sub>2</sub> max in selected patients.[<xref ref-type="bibr" rid="ref18">18</xref>] Aerobic exercise training in patients with advanced CKD also reduced VLDL and triglyceride levels, and increase HDL-cholesterol levels.[<xref ref-type="bibr" rid="ref19">19</xref>] It also improved arterial stiffness, an effect that had reversed by 1 month after training had ceased.[<xref ref-type="bibr" rid="ref20">20</xref>]</p><p><italic>Hatha yoga</italic> is becoming increasingly popular in western culture particularly as a tool for stress reduction and improving physical fitness. In eastern cultures, <italic>yoga</italic> has traditionally been a part of life, and practitioners of yoga are thought to be able to achieve high states of relaxation and self-regulation of stress. <italic>Hatha yoga</italic> uses a combination of <italic>asanas</italic> (postures), <italic>pranayamas</italic> (breathing), and <italic>dhyana</italic> (meditation). Although the exact mechanism is unknown, evidence suggests that the combination of these behaviors are most beneficial when utilized together.[<xref ref-type="bibr" rid="ref21">21</xref>] <italic>Hatha yoga</italic> is one form of physical activity that, based upon previous research, may show promise for improving the health of caregivers.[<xref ref-type="bibr" rid="ref22">22</xref><xref ref-type="bibr" rid="ref23">23</xref>] Studies carried out on medium or long-term effect of yoga exercise on lipid parameters in ESRD patients are sparse and there is only one reported study in the literature that examined the effect of a modified yoga-based exercise program on lipid parameters in hemodialysis patients.[<xref ref-type="bibr" rid="ref24">24</xref>] This study investigated the impact of <italic>Hatha yoga</italic> exercise on lipid parameters in patients with ESRD on hemodialysis.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><sec id="sec2-1"><title>Selection of subjects</title><p>The study was conducted between January 2009 and April 2009. There were two groups in the study. All the participants were recruited from the hemodialysis unit at the university hospital of the West Indies. The yoga group consisted on patients, who participated in 30 minutes of guided <italic>Hatha Yoga</italic> exercise and additional thirty minutes of instructed and unsupervised home training. The participants in the control group continued their regular lifestyle practice without direct intervention from the personnel of this investigation. The patients in the study were between 20 and 70 years of age, had no associated serious illness or harmful dependence on toxic habits and had signed consent form. The study was conducted in accordance with the Declaration of Helsinki.</p><p>Using the sample power statistical software (SPSS), set at type 1 error (alpha) = 0.05 and power of 90%, the minimum number of participants needed to pick up mean differences from normal was calculated to be five persons per group of interest. The groups of interest include analysis broken down by four age categories, two gender categories, four body mass index categories, and two overall grouping of cases versus controls. Hence a minimum of 66 participants (33 cases in the Yoga group and 33 control patients without a guided training program) were needed for this study. Cases and control patients were selected using a random sample from the sample frame of list of patients who attended that hemodialysis unit.</p><p>After obtaining informed consent, participants were asked to donate 5 ml of blood sample for lipid parameters measurements. Serum samples were processed and refrigerated within 3 hours of blood draw. The serum samples that were not assayed within 24 hours after collection, were stored at 2-8&#x000b0;C. Specimen held for longer times were stored at -70&#x000b0;C.</p></sec><sec id="sec2-2"><title>Biochemical analysis</title><p>Biochemical assays of lipid profile parameters in the serum samples were performed with a multichannel auto analyzer (c8000, Abbott Diagnostics, Abbott Park, USA). Parameters that were determined include total cholesterol (TC), triglyceride, HDL-cholesterol, and LDL-cholesterol. Total cholesterol was determined by an enzymatic method. The cholesterol esters are hydrolyzed to free cholesterol by cholesterol esterase. The free cholesterol is then oxidized by cholesterol oxidase to cholesten-3-one with the simultaneous production of hydrogen peroxide. The hydrogen peroxide produced couples with 4-aminoantipyrine and phenol, in the presence of peroxidase, to yield a chromogen with maximum absorbance at 505 nm.[<xref ref-type="bibr" rid="ref25">25</xref>] HDL-cholesterol was measured by an enzymatic method on the supernatant obtained after selective precipitation of apolipoprotein B-containing lipoproteins with phosphotungstic acid in the presence of magnesium ions and centrifugation.[<xref ref-type="bibr" rid="ref26">26</xref>] Triglyceride by an analytical methodology based on the sequence of reaction described by Fossati and colleagues.[<xref ref-type="bibr" rid="ref27">27</xref>] In this direct colorimetric procedure, serum triglycerides are hydrolyzed by lipase, and the released glycerol is assayed in a reaction catalyzed by glycerol kinase and L-alpha-glycerol-phosphate oxidase in a system that generates hydrogen peroxide. The hydrogen peroxide is monitored in the presence of horseradish peroxidase with 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone as the chromogenic system. The absorbance of this chromogen system is measured at 510 nm.[<xref ref-type="bibr" rid="ref27">27</xref>] The methods adopted by the automated instrument for the determination of the above parameters are according to the manufacturer's instruction, Abbott Laboratories (Abbott Diagnostics, Illinois, USA). Serum LDL-cholesterol was calculated according to computational procedures of Friedewald <italic>et al</italic>.:[<xref ref-type="bibr" rid="ref28">28</xref>]</p><p>[LDL-cholesterol = total cholesterol - HDL-cholesterol - triglyceride/2.2 (mmol/l)].</p><p>Normal values of different parameters in lipid profile were considered as per NCEP ATP III [1] criteria guideline.[<xref ref-type="bibr" rid="ref29">29</xref>] Total cholesterol of &#x0003c;5.18 mmol/l considered as normal, 5.18 &#x02013; 6.19 mmol/l was considered as borderline high, whereas those &#x02265;6.20 mmol/l were considered as high. Triglycerides values below 1.70 mmol/l were considered as normal; those 1.70-2.25 mmol/l were considered as border-line high, whereas values 2.26-5.64 mmol/l was considered as high and &#x02265;5.65 mmol/l considered very high. Low-density lipoprotein values &#x0003c; 2.59 mmol/l were considered normal, between 2.59 &#x02013; 3.34 mmol/l near optimal, 3.35 &#x02013; 4.12 mmol/l were considered border-line high, 4.13 &#x02013; 4.90 mmol/l was considered high, whereas values &#x0003e; 4.90 mmol/l were considered very high. High-density lipoprotein values below 1.04 mmol/l were considered as low, &#x02265;1.54 mmol/l were considered as high, and values 1.04 &#x02013; 1.53 mmol/l were considered as medium.[<xref ref-type="bibr" rid="ref29">29</xref>]</p></sec><sec id="sec2-3"><title>Statistical analysis</title><p>Values for the continuous variables were expressed as mean &#x000b1; SD. Comparisons of patients with ESRD in both groups were performed using unpaired students t-tests for independent samples, a level of <italic>P</italic> &#x0003c; 0.05 considered as statistically significant. Independent observations were assumed using the Fisher exact test and 0.05 was taken to be the cutoff for acceptability of significance levels. The study parameters showed non-Gaussian distribution and statistical significance was assessed by the Mann-Whitney U test.[<xref ref-type="bibr" rid="ref30">30</xref>] Statistics were computed using SPSS 11.5 (SPSS Inc., Chicago, Illinois, United States).</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>The mean age of the patients in the <italic>Hatha Yoga</italic> exercise group was 38.95 &#x000b1; 2.84 years while that of the control group was 44.59 &#x000b1; 2.57 years. The mean BMI of the patients in the control group was 25.74 &#x000b1; 0.50 kg/m<sup>2</sup> while that of the Hatha Yoga exercise group was 25.550 &#x000b1; 2.21 kg/m<sup>2</sup>. The patients in the control group were in hemodialysis for 4.45 &#x000b1; 0.65 years while those in the <italic>Hatha Yoga</italic> exercise group were on hemodialysis for 4.86 &#x000b1; 0.49 years.</p><p>There was a significant reduction in serum total cholesterol, triglycerides, LDL-cholesterol, and total cholesterol/HDL-cholesterol ratio, and a significant increase in HDL-cholesterol after 4 months for patients in the Hatha yoga exercise group. In the prehemodialysis <italic>Hatha Yoga</italic> exercise group there was a significant decrease in total cholesterol from 5.126 &#x000b1; 0.092 mmol/l to 4.891 &#x000b1; 0.072 mmol/l (4.58% reduction; <italic>P</italic> = 0.0001), triglycerides from 2.699 &#x000b1; 0.078 mmol/l to 2.530 &#x000b1; 0.063 mmol/l (6.26% reduction; <italic>P</italic> = 0.0001), LDL-cholesterol from 2.729 &#x000b1; 0.083 mmol/l to 2.420 &#x000b1; 0.066 mmol/l (11.32% reduction <italic>P</italic> = 0.0001), and total cholesterol/HDL-cholesterol ratio from 5.593 &#x000b1; 0.119 mmol/l to 4.907 &#x000b1; 0.116 mmol/l (12.26% reduction; <italic>P</italic> = 0.047). Furthermore, there was no significant increase in HDL-cholesterol from 0.931 &#x000b1; 0.022 mmol/l to 1.017 &#x000b1; 0.016 mmol/l [8.46% elevation; <italic>P</italic> = 0.250; <xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Lipid parameters of prehemodialysis patients in the Hatha yoga exercise group</p></caption><graphic xlink:href="JLP-4-17-g001"/></table-wrap><p>There was a significant reduction in serum total cholesterol and HDL-cholesterol, and a significant increase in triglycerides and total cholesterol/HDL-cholesterol ratio after 4 months in the control group. In patients in the prehemodialysis control group was a significant reduction in serum total cholesterol from 4.7663 &#x000b1; 0.050 mmol/l to 4.7657 &#x000b1; 0.054 mmol/l (<italic>P</italic> = 0.0001) and HDL-cholesterol from 0.898 &#x000b1; 0.015 mmol/l to 0.872 &#x000b1; 0.013 mmol/l (2.90% reduction; <italic>P</italic> = 0.0001). Furthermore, there was a significant increase in triglycerides from 3.243 &#x000b1; 0.186 mmol/l to 3.450 &#x000b1; 0.180 mmol/l (6.0% elevation; <italic>P</italic> = 0.0001) and total cholesterol/HDL-cholesterol ratio from 5.348 &#x000b1; 0.086 to 5.505 &#x000b1; 0.099 [2.9% elevation; <italic>P</italic> = 0.0001; <xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Lipid parameters of prehemodialysis patients in the control group</p></caption><graphic xlink:href="JLP-4-17-g002"/></table-wrap><p>There was significant correlation between the pre-dialysis lipid parameters of patients in the Hatha yoga exercise group at 0 month and after 4 months for total cholesterol (<italic>r</italic> = 0.655), triglycerides (<italic>r</italic> = 0.826), LDL-cholesterol (<italic>r</italic> = 0.572), and total cholesterol/HDL-cholesterol ratio (<italic>r</italic> = 0.354). Furthermore, there was significant correlation between the predialysis lipid parameters for the controls at 0 month and after 4 months for total cholesterol (<italic>r</italic> = 0.592), triglycerides (<italic>r</italic> = 0.872), HDL-cholesterol (<italic>r</italic> = 0.645), and total cholesterol/HDL-cholesterol ratio (<italic>r</italic> = 0.584).</p><p>In examining total cholesterol concentrations of patients in the prehemodialysis Hatha yoga exercise group, 51.5% had normal total cholesterol at 0 month, while at the end of therapy after 4 months 70.0% had normal total cholesterol (<italic>P</italic> &#x0003c; 0.05). The results also showed that while 63.6% of the patients in the prehemodialysis <italic>Hatha Yoga</italic> exercise group had low HDL-cholesterol after 4 months, 81.8% had low HDL-cholesterol at 0 month (<italic>P</italic> &#x0003c; 0.05). Furthermore, while 84.9% of patients in the prehemodialysis <italic>Hatha Yoga</italic> exercise group had normal LDL-cholesterol after 4 months, 54.5% had normal LDL-cholesterol at 0 month [<italic>P</italic> &#x0003c; 0.05; <xref ref-type="table" rid="T3">Table 3</xref>]. In examining total cholesterol concentrations in the control group, 85.7% and 77.1% of the patients had normal total cholesterol concentrations at 0 month and 4 months respectively. There were no significant differences in the normal triglycerides and LDL-cholesterol at 0 month compared with after 4 months in control patients [<xref ref-type="table" rid="T4">Table 4</xref>].</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Classification of lipid parameters of patients in the Hatha yoga exercise group (0 month and 4 months) according to NCEP ATP III</p></caption><graphic xlink:href="JLP-4-17-g003"/></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Classification of lipid parameters of patients in the control group (0 month and 4 months) according to NCEP ATP III</p></caption><graphic xlink:href="JLP-4-17-g004"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Patients with chronic renal insufficiency and those on chronic hemodialysis treatment are at elevated atherogenic risk, and dyslipidemia appears to be one of the major risk factors. Our study indicates an abnormal lipoprotein profile in ESRD patients on hemodialysis. The majority of the ESRD patients in both the <italic>Hatha Yoga</italic> exercise and control groups had borderline high or high triglycerides, and low HDL-cholesterol at baseline. Approximately one-tenth of the patients in both groups had high LDL-cholesterol concentrations while approximately one-half of the patients in the <italic>Hatha Yoga</italic> exercise group had borderline high or high total cholesterol. The ESRD patients engaged in <italic>Hatha Yoga</italic> exercise demonstrated significantly lower serum total cholesterol, triglycerides, LDL-cholesterol, and total cholesterol/LDL-cholesterol ratio after 4 months compared with baseline values. The risk factor for coronary artery disease (total cholesterol/HDL-cholesterol ratio) is usually elevated in renal failure patients, especially in those with hypertriglyceridemia.[<xref ref-type="bibr" rid="ref31">31</xref>] Conversely, the ESRD patients in the control group had significantly higher triglycerides and total cholesterol/HDL-cholesterol ratio, but lower HDL-cholesterol concentrations after 4 months compared with baseline values. In the only study evaluating the effects of a 12-week yoga-based exercise program on biochemical markers in a randomized controlled trial of hemodialysis patients there was significant improvements in total cholesterol and LDL-cholesterol compared with that in the control group but not so in other lipid profile variables such as HDL-cholesterol and triglyceride concentrations. The authors concluded that the simplified yoga-based rehabilitation program is a complementary, safe, and effective clinical treatment modality in patients with ESRD.[<xref ref-type="bibr" rid="ref32">32</xref>]</p><p>The results of this study are similar to that of Bijlani <italic>et al</italic>, where yoga significantly decreased serum total cholesterol, LDL-cholesterol, VLDL, triglycerides and total cholesterol/HDL-cholesterol ratio in individuals attending a lifestyle education-based program for 9 days.[<xref ref-type="bibr" rid="ref32">32</xref>] Furthermore, there are studies that have investigated the use of yoga exercise as a therapeutic intervention in cardiovascular diseases. In a study by Khare and Rai investigating the lipid profile in postmyocardial infarction subjects following yogi life style intervention, there was significant reduction in total cholesterol and LDL-cholesterol, whereas an increase in HDL-cholesterol was also noted.[<xref ref-type="bibr" rid="ref33">33</xref>] Mahajan <italic>et al</italic> reported that yoga intervention caused a decrease in all lipid parameters except HDL-cholesterol in angina patients and normal subjects with risk factors of coronary artery disease.[<xref ref-type="bibr" rid="ref34">34</xref>] Yogendra <italic>et al</italic>, reported the beneficial effects of yoga lifestyle on reversibility of ischemic heart disease as at the end of 1 year of yoga training, statistical significant reductions in serum total cholesterol, serum LDL-cholesterol, and regression of disease. The authors also suggest that yoga-based lifestyle modifications help in regression of coronary lesions and in improving myocardial perfusion which translated into clinical benefits and symptomatic improvement.[<xref ref-type="bibr" rid="ref35">35</xref>]</p><p>Chronic renal failure is often associated with dyslipidemia. Lipid profile abnormalities have been identified as an independent risk factor for atherosclerosis.[<xref ref-type="bibr" rid="ref36">36</xref><xref ref-type="bibr" rid="ref37">37</xref>] ESRD patients typically have either normal or increased LDL-cholesterol, increased VLDL and intermediate-density lipoprotein (IDL), leading to elevated triglyceride levels, and decreased levels of HDL-cholesterol. There are also qualitative changes in dyslipidemia with a shift from an atherogenic LDL particle size toward a small, dense apo-B-rich LDL predominance.[<xref ref-type="bibr" rid="ref6">6</xref>] It was reported by Alsaran <italic>et al</italic> that 40-50% of patients with ESRD have high triglycerides, 10-45% have high LDL-cholesterol, and 20-30% have high total cholesterol.[<xref ref-type="bibr" rid="ref38">38</xref>] In our study approximately 85% of the patients in both groups had high triglyceride concentrations greater than 2.26 mmol/l. Furthermore, 82-92% of the patients in both groups had low HDL-cholesterol. In the choices for healthy outcomes in caring for ESRD (CHOICE) study, 36% of hemodialysed patients had hypertriglyceridemia[<xref ref-type="bibr" rid="ref39">39</xref>] where as Pennell and colleagues found the incidence to be 52%.[<xref ref-type="bibr" rid="ref8">8</xref>] But the results of this study are not in agreement with the results of some researchers showing significantly decreased plasma triglyceride concentration in hemodialysis patients[<xref ref-type="bibr" rid="ref40">40</xref>] or no change.[<xref ref-type="bibr" rid="ref41">41</xref>] Furthermore, the atherogenic potential of dyslipidemia in kidney disease may depend more on the apolipoprotein rather than on lipid abnormalities, and may not always be recognized by measurement of plasma lipids alone,[<xref ref-type="bibr" rid="ref42">42</xref>] as suggested by Attman and Alaupovic.[<xref ref-type="bibr" rid="ref43">43</xref>]</p><p>In this study though there was not a significant increase in the mean value of HDL-cholesterol after 4 months, there was an increase in the number of patients with medium HDL-cholesterol, from 18.2% to 36.4%, with fewer people in the low category level. Some studies evaluating the long-term effect of yoga on lipid profile have demonstrated significant rise in values of HDL-cholesterol.[<xref ref-type="bibr" rid="ref44">44</xref><xref ref-type="bibr" rid="ref45">45</xref>] In the present study, there was a significant decrease in total cholesterol and triglyceride concentrations in ESRD patients on hemodialysis. Further, it was observed that some patients with borderline high total cholesterol and triglycerides values achieved normal values, whereas patients with high values achieved borderline high values. There were also some cases with high values that attained normal values. Hence, Hatha yoga intervention resulted in an overall improvement in different parameters of lipid profile and is therefore beneficial in the management of dyslipidemia in ESRD patients.</p><p>Many patients with renal failure show abnormalities of lipid metabolism. Hypertriglyceridemia and low levels of HDL-cholesterol are frequent abnormalities in uremic patients. The various disturbances of lipoprotein metabolism in uremia can be summarized as decreased catabolism of lipoproteins with an inappropriate synthesis of VLDL.[<xref ref-type="bibr" rid="ref46">46</xref>] There is decreased lipoprotein catabolism, resulting in incompletely cleared intermediate particles and diminished formation of HDL.[<xref ref-type="bibr" rid="ref47">47</xref>]</p><p>In conclusion, the findings of the study demonstrate the efficacy of <italic>Hatha Yoga</italic> exercise on lipid parameters in ESRD patients. These findings suggest that <italic>Hatha Yoga</italic> exercise has preventive and beneficial effects and may be a safe therapeutic modality in ESRD patients. Optimal management of dyslipidemia in ESRD patients with regimens such as <italic>Hatha Yoga</italic> exercise, particularly reduction of low-density lipoprotein cholesterol, should therefore lead to both cardiovascular and renal benefits.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> There is no competing financial or other interest in relation to this research.</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junyent</surname><given-names>M</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>M</given-names></name><name><surname>Borr&#x000e0;s</surname><given-names>M</given-names></name><name><surname>Coll</surname><given-names>B</given-names></name><name><surname>Valdivielso</surname><given-names>JM</given-names></name><name><surname>Vidal</surname><given-names>T</given-names></name><etal/></person-group><article-title>Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain.The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study</article-title><source>BMC Nephrol</source><year>2010</year><volume>11</volume><fpage>14</fpage><pub-id pub-id-type="pmid">20609210</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foley</surname><given-names>RN</given-names></name><name><surname>Parfrey</surname><given-names>PS</given-names></name><name><surname>Sarnak</surname><given-names>MJ</given-names></name></person-group><article-title>Clinical epidemiology of cardiovascular disease in chronic renal disease</article-title><source>Am J Kidney Dis</source><year>1998</year><volume>32</volume><issue>5 Suppl 3</issue><fpage>S112</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9820470</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Wakeel</surname><given-names>JS</given-names></name><name><surname>Mitwalli</surname><given-names>AH</given-names></name><name><surname>Al Mohaya</surname><given-names>S</given-names></name><name><surname>Abu-Aisha</surname><given-names>H</given-names></name><name><surname>Tarif</surname><given-names>N</given-names></name><name><surname>Malik</surname><given-names>GH</given-names></name><etal/></person-group><article-title>Morbidity and mortality in ESRD patients on dialysis</article-title><source>Saudi J Kidney Dis Transpl</source><year>2002</year><volume>13</volume><fpage>473</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17660670</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="book"><article-title>United States Renal Data System. USRDS (2000) Annual Data Report: Atlas of End-Stage Renal Disease in the United States (ed 12th Annual Report), Division of Kidney, Urologic and Hematological diseases</article-title><year>2000</year><publisher-loc>Bethesda, MD</publisher-loc><publisher-name>National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health</publisher-name></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prichard</surname><given-names>SS</given-names></name></person-group><article-title>Impact of dyslipidemia in end-stage renal disease</article-title><source>J Am Soc Nephrol</source><year>2003</year><volume>14</volume><issue>9 Suppl 4</issue><fpage>S315</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12939388</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Rosner</surname><given-names>MH</given-names></name></person-group><article-title>Lipid abnormalities associated with end-stage renal disease</article-title><source>Semin Dial</source><year>2006</year><volume>19</volume><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">16423180</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cases</surname><given-names>A</given-names></name><name><surname>Coll</surname><given-names>E</given-names></name></person-group><article-title>Dyslipidemia and the progression of renal disease in chronic renal failure patients</article-title><source>Kidney Int Suppl</source><year>2005</year><volume>99</volume><fpage>S87</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16336584</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennell</surname><given-names>P</given-names></name><name><surname>Leclercq</surname><given-names>B</given-names></name><name><surname>Delahunty</surname><given-names>MI</given-names></name><name><surname>Walters</surname><given-names>BA</given-names></name></person-group><article-title>The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney diseases</article-title><source>Clin Nephrol</source><year>2006</year><volume>66</volume><fpage>336</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">17140163</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cressman</surname><given-names>MD</given-names></name><name><surname>Heyka</surname><given-names>RJ</given-names></name><name><surname>Paganini</surname><given-names>EP</given-names></name><name><surname>O&#x02019;Neil</surname><given-names>J</given-names></name><name><surname>Skibinski</surname><given-names>CI</given-names></name><name><surname>Hoff</surname><given-names>HF</given-names></name></person-group><article-title>Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients</article-title><source>Circulation</source><year>1992</year><volume>86</volume><fpage>475</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">1386292</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><article-title>National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification</article-title><source>Am J Kidney Dis</source><year>2002</year><volume>39</volume><issue>2 Suppl 1</issue><fpage>S1</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">11904577</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnea</surname><given-names>N</given-names></name><name><surname>Drory</surname><given-names>Y</given-names></name><name><surname>Iaina</surname><given-names>A</given-names></name><name><surname>Lapidot</surname><given-names>G</given-names></name><name><surname>Reisin</surname><given-names>E</given-names></name><name><surname>Eliahou</surname><given-names>H</given-names></name><etal/></person-group><article-title>Exercise tolerance in patients on chronic hemodialysis</article-title><source>Isr J Med Sci</source><year>1980</year><volume>16</volume><fpage>17</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">7358510</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>G</given-names></name><name><surname>Brinker</surname><given-names>K</given-names></name><name><surname>Stray-Gundersen</surname><given-names>J</given-names></name><name><surname>Mitchell</surname><given-names>J</given-names></name></person-group><article-title>Determinants of VO 2 peak in patients with end-stage renal disease: on and off dialysis</article-title><source>Med Sci Sports Exerc</source><year>1993</year><volume>25</volume><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">8423751</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutman</surname><given-names>RA</given-names></name><name><surname>Stead</surname><given-names>WW</given-names></name><name><surname>Robinson</surname><given-names>RR</given-names></name></person-group><article-title>Physical activity and employment status of patients on maintenance dialysis</article-title><source>N Engl J Med</source><year>1981</year><volume>304</volume><fpage>309</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">7442770</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>RW</given-names></name><name><surname>Manninen</surname><given-names>DL</given-names></name><name><surname>Garrison</surname><given-names>LP</given-names></name></person-group><article-title>The quality of life of patients with end-stage renal disease</article-title><source>N Engl J Med</source><year>1985</year><volume>312</volume><fpage>553</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3918267</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Painter</surname><given-names>P</given-names></name><name><surname>Messer-Rahak</surname><given-names>D</given-names></name><name><surname>Hanson</surname><given-names>P</given-names></name><name><surname>Zimmerman</surname><given-names>SW</given-names></name><name><surname>Glass</surname><given-names>NR</given-names></name></person-group><article-title>Exercise capacity in hemodialysis, CAPD, and renal transplant patients</article-title><source>Nephron</source><year>1986</year><volume>42</volume><fpage>47</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">3510400</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zabetakis</surname><given-names>PM</given-names></name><name><surname>Gleim</surname><given-names>GW</given-names></name><name><surname>Pasternack</surname><given-names>FL</given-names></name><name><surname>Saraniti</surname><given-names>A</given-names></name><name><surname>Nicholas</surname><given-names>JA</given-names></name><name><surname>Michelis</surname><given-names>MF</given-names></name></person-group><article-title>Long-duration submaximal exercise conditioning in hemodialysis patients</article-title><source>Clin Nephrol</source><year>1982</year><volume>18</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">7116702</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>AP</given-names></name><name><surname>Geltman</surname><given-names>EM</given-names></name><name><surname>Hagberg</surname><given-names>JM</given-names></name><name><surname>Gavin</surname><given-names>JR</given-names></name><name><surname>Delmez</surname><given-names>JA</given-names></name><name><surname>Carney</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Therapeutic benefits of exercise training for hemodialysis patients</article-title><source>Kidney Int</source><year>1983</year><volume>24</volume><issue>Suppl 16</issue><fpage>S303</fpage><lpage>9</lpage></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname><given-names>KL</given-names></name></person-group><article-title>Exercise and chronic kidney disease: Current recommendations</article-title><source>Sports Med</source><year>2005</year><volume>35</volume><fpage>485</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">15974634</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>AP</given-names></name><name><surname>Geltman</surname><given-names>EM</given-names></name><name><surname>Gavin</surname><given-names>JR</given-names><suffix>III</suffix></name></person-group><article-title>Exercise training reduces coronary risk and effectively rehabilitates hemodialysis patients</article-title><source>Nephron</source><year>1986</year><volume>42</volume><fpage>311</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3960242</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustata</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>C</given-names></name><name><surname>Lai</surname><given-names>V</given-names></name><name><surname>Miller</surname><given-names>JA</given-names></name></person-group><article-title>Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><fpage>2713</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15466276</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkwood</surname><given-names>G</given-names></name><name><surname>Rampes</surname><given-names>H</given-names></name><name><surname>Tuffrey</surname><given-names>V</given-names></name><name><surname>Richardson</surname><given-names>J</given-names></name><name><surname>Pilkington</surname><given-names>K</given-names></name></person-group><article-title>Yoga for anxiety: a systematic review of the research evidence</article-title><source>Br J Sports Med</source><year>2005</year><volume>39</volume><fpage>884</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">16306493</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raub</surname><given-names>JA</given-names></name></person-group><article-title>Psychophysiologic effects of Hatha yoga on musculoskeletal and cardiopulmonary function: a literature review</article-title><source>J Altern Complement Med</source><year>2002</year><volume>8</volume><fpage>797</fpage><lpage>812</lpage><pub-id pub-id-type="pmid">12614533</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolasinski</surname><given-names>SL</given-names></name><name><surname>Garfinkel</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>AG</given-names></name><name><surname>Matz</surname><given-names>W</given-names></name><name><surname>Van Dyke</surname><given-names>A</given-names></name><name><surname>Schumacher</surname><given-names>HR</given-names></name></person-group><article-title>Iyengar yoga for treating symptoms of osteoarthritis of the knees: A pilot study</article-title><source>J Altern Complement Med</source><year>2005</year><volume>11</volume><fpage>689</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16131293</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yurtkuran</surname><given-names>M</given-names></name><name><surname>Alp</surname><given-names>A</given-names></name><name><surname>Yurtkuran</surname><given-names>M</given-names></name><name><surname>Dilek</surname><given-names>K</given-names></name></person-group><article-title>A modified yoga-based exercise program in hemodialysis patients: a randomized controlled study</article-title><source>Complement Ther Med</source><year>2007</year><volume>15</volume><fpage>164</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">17709061</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allain</surname><given-names>CC</given-names></name><name><surname>Poon</surname><given-names>LS</given-names></name><name><surname>Chan</surname><given-names>CS</given-names></name><name><surname>Richmond</surname><given-names>W</given-names></name><name><surname>Fu</surname><given-names>PC</given-names></name></person-group><article-title>Enzymatic determination of total serum cholesterol</article-title><source>Clin Chem</source><year>1974</year><volume>20</volume><fpage>470</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">4818200</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burstein</surname><given-names>M</given-names></name><name><surname>Scholnick</surname><given-names>HR</given-names></name><name><surname>Morfin</surname><given-names>R</given-names></name></person-group><article-title>Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions</article-title><source>J Lipid Res</source><year>1970</year><volume>11</volume><fpage>583</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">4100998</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fossati</surname><given-names>P</given-names></name><name><surname>Prencipe</surname><given-names>L</given-names></name></person-group><article-title>Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide</article-title><source>Clin Chem</source><year>1982</year><volume>28</volume><fpage>2077</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">6812986</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>Wi&#x02019;</given-names></name><name><surname>Levy</surname><given-names>RI</given-names></name><name><surname>Fredrickson</surname><given-names>DS</given-names></name></person-group><article-title>Estimation of the concentrationof lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title><source>Clin Chem</source><year>1972</year><volume>18</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">4337382</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><article-title>Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)</article-title><source>J Am Med Assoc</source><year>2001</year><volume>285</volume><fpage>2486</fpage><lpage>97</lpage></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Feinstein</surname><given-names>A</given-names></name></person-group><article-title>Clinical epidemiology, the architecture of clinical research</article-title><year>1985</year><edition>1st ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>WB Saunders Co</publisher-name></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>MK</given-names></name></person-group><article-title>Lipid metabolism in renal failure</article-title><source>Clin Biochem</source><year>1990</year><volume>23</volume><fpage>61</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">2184958</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bijlani</surname><given-names>RL</given-names></name><name><surname>Vempati</surname><given-names>RP</given-names></name><name><surname>Yadav</surname><given-names>RK</given-names></name><name><surname>Ray</surname><given-names>RB</given-names></name><name><surname>Gupta</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><etal/></person-group><article-title>A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus</article-title><source>J Altern Complement Med</source><year>2005</year><volume>11</volume><fpage>267</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">15865492</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khare</surname><given-names>KC</given-names></name><name><surname>Rai</surname><given-names>S</given-names></name></person-group><article-title>Study of lipid profile in post myocardial infarction subjects following yogic life style intervention</article-title><source>The Indian Practitioner</source><year>2002</year><volume>55</volume><fpage>369</fpage><lpage>73</lpage></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>AS</given-names></name><name><surname>Reddy</surname><given-names>KS</given-names></name><name><surname>Sachdeva</surname><given-names>U</given-names></name></person-group><article-title>Lipid profile of coronary risk subjects following yogic lifestyle intervention</article-title><source>Indian Heart J</source><year>1999</year><volume>51</volume><fpage>37</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">10327777</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yogendra</surname><given-names>J</given-names></name><name><surname>Yogendra</surname><given-names>HJ</given-names></name><name><surname>Ambardekar</surname><given-names>S</given-names></name><etal/></person-group><article-title>Beneficial effects of yoga lifestyle on reversibility of ischaemic heart disease: caring heart project of International Board of Yoga</article-title><source>J Assoc Physicians India</source><year>2004</year><volume>52</volume><fpage>283</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15636328</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assman</surname><given-names>G</given-names></name><name><surname>Schulte</surname><given-names>H</given-names></name></person-group><article-title>Relation of high density lipoprotein cholesterols and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience).Prospective cardiovascular munster study</article-title><source>Am J Cardiol</source><year>1992</year><volume>70</volume><fpage>733</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1519522</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hokanson</surname><given-names>JE</given-names></name><name><surname>Austin</surname><given-names>MA</given-names></name></person-group><article-title>Plasma triglyceride level is a risck factor for cardiovascular disease independent of high density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies</article-title><source>J Cardiovasc Risk</source><year>1996</year><volume>3</volume><fpage>213</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8836866</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsaran</surname><given-names>K</given-names></name><name><surname>Sabry</surname><given-names>A</given-names></name><name><surname>Shaheen</surname><given-names>N</given-names></name></person-group><article-title>Is non-fasting non-high-density lipoprotein cholesterol adequate for lipid management in Saudi hemodialysis patients?</article-title><source>J Nephrology and Renal Transplantation</source><year>2009</year><volume>2</volume><fpage>1</fpage><lpage>17</lpage></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longenecker</surname><given-names>JC</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Powe</surname><given-names>NR</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Fink</surname><given-names>NE</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study</article-title><source>J Am Soc Nephrol</source><year>2002</year><volume>13</volume><fpage>1918</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">12089389</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibels</surname><given-names>LS</given-names></name><name><surname>Simons</surname><given-names>LA</given-names></name><name><surname>King</surname><given-names>JD</given-names></name></person-group><article-title>Plasma post heparin lipolytic activity and triglyceride clearance in uremic hemodialysis patients and renal allograft recipients</article-title><source>Lab Clin Med</source><year>1976</year><volume>87</volume><fpage>648</fpage><lpage>58</lpage></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>BK</given-names></name><name><surname>Jindal</surname><given-names>SK</given-names></name><name><surname>Rana</surname><given-names>DS</given-names></name></person-group><article-title>Absence of hyperlipidemia in patients of chronic renal failure in Chandigarh</article-title><source>Indian J Med Res</source><year>1980</year><volume>72</volume><fpage>461</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">7461778</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kronenberg</surname><given-names>F</given-names></name><name><surname>Kuen</surname><given-names>E</given-names></name><name><surname>Ritz</surname><given-names>E</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>P</given-names></name><name><surname>Kraatz</surname><given-names>G</given-names></name><name><surname>Lhotta</surname><given-names>K</given-names></name><etal/></person-group><article-title>Apolipoprotein A-IV serum concentrations are elevated in mild and moderate renal failure</article-title><source>J Am Soc Nephrol</source><year>2002</year><volume>13</volume><fpage>461</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11805176</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attman</surname><given-names>PO</given-names></name><name><surname>Alaupovic</surname><given-names>P</given-names></name></person-group><article-title>Lipid and apolipoprotein profiles of uremic dyslipoproteinemia.Relation to renal function and dialysis</article-title><source>Nephron</source><year>1991</year><volume>57</volume><fpage>401</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">2046821</pub-id></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdich</surname><given-names>C</given-names></name><name><surname>Toubro</surname><given-names>S</given-names></name><name><surname>Buemann</surname><given-names>B</given-names></name><name><surname>Holst</surname><given-names>JJ</given-names></name><name><surname>B&#x000fc;low</surname><given-names>J</given-names></name><name><surname>Simonsen</surname><given-names>L</given-names></name><etal/></person-group><article-title>Leptin levels are associated with fat oxidation and dietary-induced weight loss in obesity</article-title><source>Obes Res</source><year>2001</year><volume>9</volume><fpage>452</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">11500525</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jequier</surname><given-names>E</given-names></name><name><surname>Tappy</surname><given-names>L</given-names></name></person-group><article-title>Regulation of body weight in humans</article-title><source>Physiol Rev</source><year>1999</year><volume>79</volume><fpage>451</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">10221987</pub-id></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heuck</surname><given-names>CC</given-names></name><name><surname>Ritz</surname><given-names>E</given-names></name></person-group><article-title>Hyperlipoproteinemia in renal insufficiency</article-title><source>Nephron</source><year>1980</year><volume>25</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">6986036</pub-id></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Querfeld</surname><given-names>U</given-names></name></person-group><article-title>Disturbances of lipid metabolism in children with chronic renal failure</article-title><source>Pediatric Nephrology</source><year>1993</year><volume>7</volume><fpage>749</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">8130098</pub-id></element-citation></ref></ref-list></back></article>